ANUBHAV (ANUBHAV) Fair Value & Analysis
· Market cap ₹225M
Fair value as of: Jul 5, 2026
From 14 valuation models · updated today
Share price +529.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹7.76 – ₹80.00 · fair‑value band ₹15.22 – ₹24.05 · the ₹61.92 price screens above the ₹19.64 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
ANUBHAV (ANUBHAV) currently trades at ₹61.92, while our model-based Fair Value estimate is ₹19.64 — implying the stock looks roughly 68.3% overvalued today. We read business quality at 60/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, ANUBHAV generated revenue of ₹1.1B at a net margin of 6.5%. It earns a return on equity of 42.2%. Fundamentals as of Jul 5, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
ANUBHAV reported revenue of ₹222M in FY2023 versus ₹5.3M in FY2019, a compound +154.1%/yr. Reported net income was ₹3.9M in FY2023, compounding +158.1%/yr from FY2019.
Is ANUBHAV fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is ANUBHAV (ANUBHAV) undervalued?
What is the fair value of ANUBHAV?
What is the quality score of ANUBHAV?
What is the revenue of ANUBHAV (ANUBHAV)?
What is the net profit margin of ANUBHAV?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.